EP Lab

This channel includes news and new technology innovations for cardiac electrophysiology (EP) systems, techniques and devices using in EP labs. This includes implantable EP devices, pacemakers, implantable cardioverter defibrillators (ICD), cardiac resychronization therapy (CRT), ablation technologies, left atrial appendage (LAA) occlusion, atrial fibrilation (AF) and Holter monitors.

Technology

January 21, 2019 — Abbott announced U.S. Food and Drug Administration (FDA) approval of the TactiCath Contact Force ...

Home January 21, 2019
Home
Researchers raised the question whether an economic benefit should be assessed in FDA reviews. A large amount of the bill for atrial fibrillation catheter ablation procedures is the cost of the mapping and ablation catheters.
Feature | Cardiovascular Business | Philip Jacobs, DPhil, Ilke Akpinar, M.D., Thanh Nguyen, M.D., Ph.D., Rupinder Sandhu, M.D., and Lars Thording Ph.D.

In an age when everything in medicine is now looked at though a cost vs. benefit analysis and U.S. government healthcare ...

Home January 14, 2019
Home
The startup company Genetesis introduced a new cardiac imaging modalityit calls magnetocardiography. The scanner creates images from the biomagnetic activity of the heart, using the polarization and depolarization of the heart during the cardiac cycle. This was at AHA.18, AHA 2018 - the American Heart Association annual meeting
Feature | AHA | Dave Fornell, Editor

Here are a few of the takeaways from the clinical studies presented and new technology shown on the exhibit floor at the ...

Home January 14, 2019
Home
An implanted ICD showing its three venous leads. These multiple CRT leads can cause issues when they need to be replaced and are abandoned with new leads put over them in the SVC, which may require lead extraction.
Feature | EP Lab | Dave Fornell, Editor

To extract or abandon broken or infected implantable, venous electrophysiology (EP) device leads has been a debate for ...

Home January 13, 2019
Home
The 2018 Most Popular Cardiology Topics - FDA approval of Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), and new pacemaker technologies.
Feature | Dave Fornell, Editor

January 4, 2018 — Here is the top cardiology content on the Diagnostic and Interventional Cardiology (DAIC) website from ...

Home January 04, 2019
Home
Technology | Vascular Closure Devices

December 20, 2018 — Cardiva Medical Inc. announced the company has received premarket approval (PMA) from the U.S. Food ...

Home December 20, 2018
Home
News | Atrial Fibrillation

December 18, 2018 — Irish medical device company AuriGen Medical won the prestigious Global Innovation Award at the ...

Home December 18, 2018
Home
News | EP Lab

December 14, 2018 — The Department of Health and Human Services (HHS) recently entered into an interagency agreement ...

Home December 14, 2018
Home
News | EP Lab

December 10, 2018 — Electrophysiology, while currently a relatively small market at $4.6 billion in 2018, has recently ...

Home December 10, 2018
Home
Vagal Maneuvers With Supraventricular Tachycardia
Feature | EP Lab

December 5, 2018 — Supraventricular tachycardia (SVT) is a common heart abnormality that presents as a fast heart rate ...

Home December 05, 2018
Home
News

November 30, 2018 — Johnson & Johnson Medical Devices Companies announced that Biosense Webster Inc. has enrolled and ...

Home November 30, 2018
Home
Videos | AHA

DAIC Editor Dave Fornell takes a tour of some of the most innovative new cardiovascular technologies on display on the ...

Home November 19, 2018
Home
Videos | EP Lab

Wilber Su, M.D., chief of cardiac electrophysiology, Banner University Medical Center, Phoenix, and clinical associate ...

Home November 15, 2018
Home
News | Vascular Closure Devices

November 12, 2018 — The Vascade MVP vascular closure system met its endpoints compared to manual compression in a ...

Home November 11, 2018
Home
Subscribe Now